Vestibular function in military pilots before and after 10 s at +9 Gz on a centrifuge.

Vestibular Laboratory, Institute of Aviation Medicine, Beijing, P. R. China.
Aviation Space and Environmental Medicine (Impact Factor: 0.78). 02/2009; 80(1):20-3. DOI: 10.3357/ASEM.2186.2009
Source: PubMed

ABSTRACT Effects of high Gz acceleration can threaten flight safety through loss of consciousness or a lesser-known phenomenon, G-induced vestibular dysfunction (GIVD). There are reports of GIVD following high-G flight or centrifuge exposure. The aim of this study was to explore this problem under controlled conditions using a human centrifuge.
There were 11 pilots who were exposed to +9 Gz for 10 s. Measurements were made before and after G exposure to assess vestibular function, including spontaneous nystagmus, positioning nystagmus, optokinetic nystagmus, vestibular ocular reflex, vestibular-vision interaction, subjective vision vertical perception, and vestibular-evoked myogenic potentials.
No significant change was found for vestibular function after the Gz exposure.
It appears +9 Gz for 10 s does not produce GIVD. However, the possible effects of prolonged high G maneuvers in modern aircraft combined with head movements may warrant further study.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Melatonin and light treatment are recommended for hastening adaptation to time zone change. We evaluated an afternoon regimen of 3 mg sustained release (SR) melatonin with and without next morning green light treatment for circadian phase advance. Effects of melatonin and light were tested separately and then combined to determine if the total phase change is additive or synergistic. For each condition (melatonin, placebo, light, melatonin plus light), 11 subjects spent from Tuesday evening until Friday afternoon in the laboratory. For all four conditions, the following sleep schedule was maintained: night 1, 2345 to 0630 hours, night 2, 1600 to 0530 hours, and night 3, 2345 to 0700 hours. For the light-only condition, light treatment was administered between 0700 and 0800 hours on Thursday. For melatonin-only or placebo conditions, capsules were administered at 1600 hours on Wednesday. For the combined condition, melatonin was administered at 1600 hours on Wednesday with light treatment between 0600 and 0700 hours on Thursday. Circadian phase was assessed by calculating dim light melatonin onset (DLMO) from salivary melatonin, using a mean baseline +2 standard deviations (BL+2 SD) threshold. For all four conditions, pre-treatment and post-treatment DLMO assessments were on Tuesday and Thursday evenings, respectively. Phase advances were: melatonin at 1600 hours, 0.72 h p<0.005, light treatment from 0700 to 0800 hours, 0.31 h, non-significant, and the combined treatment, 1.04 h p<0.0002. The phase advance from the combination of afternoon melatonin with next morning light is additive.
    Psychopharmacology 11/2010; 214(2):515-23. · 4.06 Impact Factor